<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>MedWorm Tags: cutting edge</title>
        <description>MedWorm provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest medical blog items that have been tagged with 'cutting edge'.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=%22cutting+edge%22&t=%22cutting+edge%22&r=Exact&o=d&f=tag]]></link>
        <lastBuildDate>Sat, 03 Sep 2011 02:22:53 +0100</lastBuildDate>
        <item>
            <title>Training the cardiac and thoracic surgeons of tomorrow: Time for change!</title>
            <link>http://www.medworm.com/index.php?rid=5088341&amp;cid=t_163290_7_f&amp;fid=38807&amp;url=http%3A%2F%2Fmedia.theheart.org%2Fpodcasts%2Fcutting-edge-dialogues-with-drs-tim-gardner-and-mat-williams%2FMedia%2Ftraining-the-cardiovascular-and-thoracic-surgeons-of-tomorrow-time-for-change.mp4</link>
            <description>Training the cardiac and thoracic surgeons of tomorrow. Current training emphasizes general and complex laparoscopic procedures at the expense of developing skills in the cath and echo labs. It's time for radical change. (Source: Blogs@theHeart.org)</description>
            <author>Blogs@theHeart.org</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=5088341</comments>
            <pubDate>Tue, 02 Aug 2011 18:15:00 +0100</pubDate>
            <guid isPermaLink="false">5088341</guid>        </item>
        <item>
            <title>Two cautionary notes on TAVI</title>
            <link>http://www.medworm.com/index.php?rid=4873215&amp;cid=t_163290_7_f&amp;fid=38807&amp;url=http%3A%2F%2Fmedia.theheart.org%2Fpodcasts%2Fcutting-edge-dialogues-with-drs-tim-gardner-and-mat-williams%2FMedia%2Ftwo-cautionary-notes-on-tavi.mp4</link>
            <description>While celebrating a remarkable new paradigm of treatment for high risk patients with aortic stenosis, incidences of perivalvular leak and cerebral embolization, as reported at the recent EuroPCR and AATS meetings, serve as reminders that TAVI is novel. (Source: Blogs@theHeart.org)</description>
            <author>Blogs@theHeart.org</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4873215</comments>
            <pubDate>Fri, 27 May 2011 14:00:00 +0100</pubDate>
            <guid isPermaLink="false">4873215</guid>        </item>
        <item>
            <title>Surgeons and interventionalists partner to ensure best care</title>
            <link>http://www.medworm.com/index.php?rid=4698232&amp;cid=t_163290_7_f&amp;fid=38807&amp;url=http%3A%2F%2Fmedia.theheart.org%2Fpodcasts%2Fcutting-edge-dialogues-with-drs-tim-gardner-and-mat-williams%2FMedia%2Fsurgeons-and-interventionalists-partner-to-ensure-best-care.mp4</link>
            <description>The &amp;quote;heart-valve team&amp;quote;—collaboration between cardiovascular surgeon and interventional cardiologist—is key to the outstanding results from PARTNER cohort A presented last week at the ACC meeting. Can this collaboration endure? (Source: Blogs@theHeart.org)</description>
            <author>Blogs@theHeart.org</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4698232</comments>
            <pubDate>Mon, 11 Apr 2011 15:00:00 +0100</pubDate>
            <guid isPermaLink="false">4698232</guid>        </item>
        <item>
            <title>Spotlight on the right internal thoracic artery</title>
            <link>http://www.medworm.com/index.php?rid=4437053&amp;cid=t_163290_7_f&amp;fid=38807&amp;url=http%3A%2F%2Fmedia.theheart.org%2Fpodcasts%2Fcutting-edge-dialogues-with-drs-tim-gardner-and-mat-williams%2FMedia%2Fspotlight-on-the-right-internal-thoracic-artery.mp4</link>
            <description>Exciting results, spanning more than 20 years of research, presented by Dr James Tatoulis at the Society of Thoracic Surgeons (STS) 2011 Annual Meeting, indicate that the RITA graft is as effective as the more frequently used left internal thoracic artery (Source: Blogs@theHeart.org)</description>
            <author>Blogs@theHeart.org</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4437053</comments>
            <pubDate>Fri, 04 Feb 2011 21:05:00 +0100</pubDate>
            <guid isPermaLink="false">4437053</guid>        </item>
        <item>
            <title>Introducing Neuroscience and Relationships</title>
            <link>http://www.medworm.com/index.php?rid=4302162&amp;cid=t_163290_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2010%2F12%2F31%2Fintroducing-neuroscience-and-relationships%2F</link>
            <description>Well, as we say goodbye to another year, I have an early new year&amp;#8217;s present for everyone &amp;#8212; a new blog! I&amp;#8217;m pleased to introduce Neuroscience and Relationships with Dr. Athena Staik.
Dr. Athena Staik has been studying the brain, the neuroscience of attachments, and cutting edge tools for accelerated success and human change for over 10 years. With a Ph.D. in marriage and family therapy, and an MA and BA in psychology, her work is influenced by a wide range of psychological models, with an emphasis on positive, strengths-based approaches.
“On this blog, I’d like to share some of the methods I use, principles, recent findings as it relates to the brain and healthy personal lives and relationships, how understanding how our brain and body are designed is an essential part...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4302162</comments>
            <pubDate>Fri, 31 Dec 2010 14:29:57 +0100</pubDate>
            <guid isPermaLink="false">4302162</guid>        </item>
        <item>
            <title>Video: “The Too-Informed Patient”</title>
            <link>http://www.medworm.com/index.php?rid=4251108&amp;cid=t_163290_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fvideo-the-too-informed-patient%2F2010.12.11</link>
            <description>This video, &amp;#8220;The Too-Informed Patient,&amp;#8221; came my way lately. It&amp;#8217;s featured on NPR’s Mar­ket­place website:

The Too Informed Patient from Marketplace on Vimeo.
&amp;#8212;&amp;#8211;
The pup­peteer skit fea­tures the inter­ac­tion between a young man with a rash and his older physi­cian. The patient is an informed kind of guy: He’s checked his own med­ical record on the doctor’s web­site, read up on rashes in the Boston Globe, checked pix on WebMD, seen an episode of &amp;#8220;Gray’s Anatomy&amp;#8221; about a rash and, most inven­tively, checked iDiagnose, a hypo­thet­i­cal app (I hope) that led him to the con­clu­sion that he might have epi­der­mal necro­sis.
&amp;#8220;Not to worry,&amp;#8221; the patient informs Dr. Matthews, who mean­while has been try­ing to ex...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4251108</comments>
            <pubDate>Sat, 11 Dec 2010 19:00:28 +0100</pubDate>
            <guid isPermaLink="false">4251108</guid>        </item>
        <item>
            <title>Surgeons and interventionalists learn from PARTNER</title>
            <link>http://www.medworm.com/index.php?rid=4208622&amp;cid=t_163290_7_f&amp;fid=38807&amp;url=http%3A%2F%2Fmedia.theheart.org%2Fpodcasts%2Fcutting-edge-dialogues-with-drs-tim-gardner-and-mat-williams%2FMedia%2Fsurgeons-and-interventionalists-learn-from-partner.mp4</link>
            <description>The results of the PARTNER trial point the way to a new standard of care for patients with severe symptomatic aortic stenosis in an era of close collaboration between cardiovascular surgeons and interventional cardiologists. (Source: Blogs@theHeart.org)</description>
            <author>Blogs@theHeart.org</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4208622</comments>
            <pubDate>Mon, 29 Nov 2010 21:15:00 +0100</pubDate>
            <guid isPermaLink="false">4208622</guid>        </item>
        <item>
            <title>Recognizing the heart team: Surgeon and interventional cardiologist join forces for better outcomes</title>
            <link>http://www.medworm.com/index.php?rid=3955709&amp;cid=t_163290_7_f&amp;fid=38807&amp;url=http%3A%2F%2Fmedia.theheart.org%2Fpodcasts%2Fcutting-edge-dialogues-with-drs-tim-gardner-and-mat-williams%2FMedia%2Frecognizing-the-heart-team-surgeon-and-interventional-cardiologist-join-forces-for-better-outcomes.mp4</link>
            <description>Cutting-edge dialogues with Drs Tim Gardner and Mat Williams - The aims of this exchange are to offer insight into the ever-evolving world of cardiovascular surgery and provide a forum for debate for surgeons, interventional cardiologists, and the wider cardiovascular community. (Source: Blogs@theHeart.org)</description>
            <author>Blogs@theHeart.org</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3955709</comments>
            <pubDate>Fri, 10 Sep 2010 15:04:00 +0100</pubDate>
            <guid isPermaLink="false">3955709</guid>        </item>
        <item>
            <title>Have We Killed Clinical Research?</title>
            <link>http://www.medworm.com/index.php?rid=3607500&amp;cid=t_163290_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Fhave-we-killed-clinical-research%2F2010.05.27</link>
            <description>&amp;#8220;&amp;#8230;I have always depended on the kindness of strangers.&amp;#8221;  &amp;#8212; Blanche DuBois in Tennessee Williams&amp;#8217; play A Streetcar Named Desire
Years ago when I began my medical training, I recall enrolling patients for clinical research. In cardiology, there were a myriad of questions that needed to be answered, especially in the area of defining which medications were best to limit the damage caused by a heart attack.
Patients routinely participated in large, multi-center prospective randomized trials to answer these questions. It was routine for them not to charged for participating in the trial &amp;#8212; the drug(s) and additional testing would be funded by the company whose drug was being studied. Patients enrolled willingly, eager to help advance science and perhaps, in s...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3607500</comments>
            <pubDate>Thu, 27 May 2010 16:00:00 +0100</pubDate>
            <guid isPermaLink="false">3607500</guid>        </item>
        <item>
            <title>Low-Dose Naltrexone: Medical Revolution Or Pseudoscience?</title>
            <link>http://www.medworm.com/index.php?rid=3560233&amp;cid=t_163290_87_f&amp;fid=39187&amp;url=http%3A%2F%2Fgetbetterhealth.com%2Flow-dose-naltrexone-medical-revolution-or-pseudoscience%2F2010.05.13</link>
            <description>On SBM we have documented the many and various ways that science is abused in the pursuit of health (or making money from those who are pursuing health). One such method is to take a new, but reasonable, scientific hypothesis and run with it, long past the current state of the evidence. We see this with the many bogus stem cell therapy clinics that are popping up in parts of the world with lax regulation.
This type of medical pseudoscience is particularly challenging to deal with, because there is a scientific paper trail that seems to support many of the claims of proponents. The claims themselves may have significant plausibility, and parts of the claims may in fact be true. Efforts to educate the public about such treatments are frustrated by the mainstream media’s lazy tendency to di...</description>
            <author>Better Health</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3560233</comments>
            <pubDate>Thu, 13 May 2010 12:00:52 +0100</pubDate>
            <guid isPermaLink="false">3560233</guid>        </item>
        <item>
            <title>Drugmakers Place Caps On Speaker Fees: Study</title>
            <link>http://www.medworm.com/index.php?rid=2950991&amp;cid=t_163290_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeedproxy.google.com%2F%7Er%2FPharmalot%2F%7E3%2F_jGXngEftwM%2F</link>
            <description>As the controversy rages over speaker fees given to physicians, some drug and device makers claim they have instituted annual compensation caps, at least according to a new survey of some 40 companies. To wit, 71 percent of drugmakers and 67 percent of device makers say they have taken this step, according to Cutting Edge Information, a research firm. Its survey also shows all large drugmakers have instituted a cap, but only 56 percent of smaller ones have done so.
Large and small was defined based on rankings by Pharmaceutical Executive magazine. In any event, the average large pharma cap is is $69,000, almost $25,000 more than the average annual cap of $44,800 for all drugmakers. Interestingly, small drugmakers have the next highest cap at $57,000. Mid-size companies maintain a cap of $3...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2950991</comments>
            <pubDate>Mon, 02 Nov 2009 14:15:49 +0100</pubDate>
            <guid isPermaLink="false">2950991</guid>        </item>
        <item>
            <title>APA: Website Design Tips Circa 1997</title>
            <link>http://www.medworm.com/index.php?rid=2681956&amp;cid=t_163290_109_f&amp;fid=34750&amp;url=http%3A%2F%2Fpsychcentral.com%2Fblog%2Farchives%2F2009%2F08%2F07%2Fapa-website-design-tips-circa-1997%2F</link>
            <description>Since I decided not to attend this year&amp;#8217;s annual convention of American psychologists (held, ironically, in Toronto this year), I&amp;#8217;ve been following their blog. This is the first year the APA has done a blog about the convention, 10 years after blogs become popular. I guess better late than never is the theme.
And I can&amp;#8217;t help but think that&amp;#8217;s the theme for some of the approved talks, like this cutting-edge talk about Enhancing Your Web Site. I&amp;#8217;m sorry, but really? I don&amp;#8217;t mean to be critical, but this is the kind of advice I&amp;#8217;d expect to see (and that I think I actually gave to a previous convention) circa 1997. Not 2009. You could&amp;#8217;ve saved yourself the 50 minute talk with it being boiled down to:

Website design is like any other professional...</description>
            <author>World of Psychology</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2681956</comments>
            <pubDate>Fri, 07 Aug 2009 18:32:50 +0100</pubDate>
            <guid isPermaLink="false">2681956</guid>        </item>
        <item>
            <title>Meet And Greet, But Not Spending As Much</title>
            <link>http://www.medworm.com/index.php?rid=1526773&amp;cid=t_163290_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F314831472%2F</link>
            <description>Looks like there&amp;#8217;s less money spent for all those meetings this year. You know, the get-togethers for the marketing staff; dinners for investigators and advisory board members; gatherings for product launches and strategy sessions. The results were compiled by Cutting Edge Info, which queried 21 drug and device makers, and biotechs. Of course, if some companies really want to cut back, they would quit giving goodies to employs just for showing up to a meeting. We hear a few spendthrifts still persist. (Source: Pharmalot)</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1526773</comments>
            <pubDate>Wed, 18 Jun 2008 19:12:36 +0100</pubDate>
            <guid isPermaLink="false">1526773</guid>        </item>
        <item>
            <title>Brains Engage at King's College London</title>
            <link>http://www.medworm.com/index.php?rid=1386943&amp;cid=t_163290_109_f&amp;fid=35677&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainBasedBusiness%2F%7E3%2F274329312%2Fbrains_engaged_at_kings_colleg.html</link>
            <description>If you wonder how King&amp;rsquo;s College London made it into the world&amp;rsquo;s top 25 universities &amp;hellip; you likely also wonder about dividends from brains at work.&amp;nbsp;It involves seizing opportunities&amp;nbsp;... as well as&amp;nbsp;creating winning distinctives.&amp;nbsp;In contrast ... &amp;nbsp;at less successful universities &amp;hellip; some claim that students demand more and give less. Others blame higher education faculty for resisting changes that rejuvenate learning. King&amp;rsquo;s stands out as a higher education campus that looks to opportunities for growth ... and then welcomes partnerships to make it happen. Their golden status raises the question &amp;hellip; &amp;nbsp;what makes any organization top among competitors? Here on King&amp;rsquo;s campus &amp;hellip; the brain is at work to spotlight concrete w...</description>
            <author>BrainBasedBusiness</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1386943</comments>
            <pubDate>Mon, 21 Apr 2008 00:38:40 +0100</pubDate>
            <guid isPermaLink="false">1386943</guid>        </item>
        <item>
            <title>Has The Medical Affairs Department Left Marketing?</title>
            <link>http://www.medworm.com/index.php?rid=1322424&amp;cid=t_163290_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F257003360%2F</link>
            <description>A recent survey indicates that pharma&amp;#8217;s medical affairs departments aren&amp;#8217;t reporting to marketing as much as in the past, most likely due to compliance concerns. Back in 2002, 43 percent of the department were under the marketing roof, but this dropped to 7 percent this year, according to the Cutting Edge research firm, which queried 14 drugmakers, including Amgen, Glaxo, Bayer, Biogen Idec and Novartis.
Medical affairs, by the way, was defined as including these functions: thought leader development, MSL programs, medical publications, medical education, medical information, investigator-initiated, medical grants, advisory boards and advocacy, pharmacovigilance, patient assistance, Phase IV research, or clinical trials. Of course, some will argue these functions continue to se...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1322424</comments>
            <pubDate>Mon, 24 Mar 2008 12:16:54 +0100</pubDate>
            <guid isPermaLink="false">1322424</guid>        </item>
        <item>
            <title>What's Inside Progressive Universities?</title>
            <link>http://www.medworm.com/index.php?rid=1251170&amp;cid=t_163290_109_f&amp;fid=35677&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainBasedBusiness%2F%7E3%2F239662396%2Fwhats_inside_progressive_unive.html</link>
            <description>If you can imagine a university where:1. Learners enroll for its international vitality.2. Faculty exchange cutting edge ideas beyond class.3. Communities balance care with challenge and vision.&amp;nbsp;You&amp;rsquo;ll want to compare how: 1. Learners drop out rates escalate from boredom2. Faculty ideas dim behind bulging bureaucracies3. Communities stifle talents for tired conventions.Then you&amp;rsquo;ll likely agree:1. Learner connections could dip deeper and broader.2. Faculty enthusiasm and passion could fuel growth.3. Communities could restructure to generate change.What would be&amp;nbsp;your first step to: 1. Re-energized learners at university? 2. Faculty leaders who risk more than rant?3. Communities that progress and evolve often? (Source: BrainBasedBusiness)</description>
            <author>BrainBasedBusiness</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1251170</comments>
            <pubDate>Fri, 22 Feb 2008 22:44:38 +0100</pubDate>
            <guid isPermaLink="false">1251170</guid>        </item>
        <item>
            <title>Thwarting Generics: Step One, Proscratinate</title>
            <link>http://www.medworm.com/index.php?rid=1134008&amp;cid=t_163290_150_f&amp;fid=35777&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FPharmalot%2F%7E3%2F212683178%2F</link>
            <description>In a perfect world, we could take our time to meet challenges. Brand-name drugmakers, however, do not have that luxury. A new report, however, suggests some must believe otherwise. After surveying big pharma for its &amp;#8216;Combatting Generics&amp;#8217; study, Cutting Edge finds that 66 percent do not begin counter-generics planning until at least two years after a product has launched.
Although product teams often feel that they should not be planning for generics until well after a successful launch and period of brand maturation, veteran brand managers consistently report that teams start counterinsurgency planning far too late in a drug’s life, according to the executive summary. (You can take a peek by starting here).
The research firm then goes on to say something recognizable: &amp;#8220;...</description>
            <author>Pharmalot</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1134008</comments>
            <pubDate>Mon, 07 Jan 2008 17:07:13 +0100</pubDate>
            <guid isPermaLink="false">1134008</guid>        </item>
        <item>
            <title>An Evening of More Than The Past, Present, Future: Part 1</title>
            <link>http://www.medworm.com/index.php?rid=888598&amp;cid=t_163290_145_f&amp;fid=35710&amp;url=http%3A%2F%2Fksdescartin.wordpress.com%2F2007%2F09%2F20%2Fan-evening-of-more-than-the-past-present-future-part-1%2F</link>
            <description>Yesterday, September 19th was the kick off for the series of lectures at the Continuing Studies program at Rice University. It was at Sewall Hall at the Rice Campus. Dr. Denton A. Cooley, the pioneer of human heart transplant in the United States, still observably sprightly at 87, was the lecturer for the day. He is currently president and surgeon-in-chief at the Texas Heart Institute; program director for the Texas Heart Institute/Baylor College of Medicine Thoracic Residency Program; and chief of cardiovascular surgery at St. Luke’s Episcopal Hospital. Here are some of my notes on this experience.
Dr. Cooley, His Influences, and The People He Worked With
He performed the first successful human heart transplant in the United States in 1968. In 1969, he became the first heart surgeon to ...</description>
            <author>the story of healing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=888598</comments>
            <pubDate>Thu, 20 Sep 2007 19:25:33 +0100</pubDate>
            <guid isPermaLink="false">888598</guid>        </item>
        <item>
            <title>Cutting-Edge Developments at Baylor College of Medicine and the Texas Heart Institute</title>
            <link>http://www.medworm.com/index.php?rid=853138&amp;cid=t_163290_145_f&amp;fid=35710&amp;url=http%3A%2F%2Fksdescartin.wordpress.com%2F2007%2F09%2F09%2Fcutting-edge-developments-at-baylor-college-of-medicine-and-the-texas-heart-institute%2F</link>
            <description>I am very much looking forward to these series of lectures happening in less than a couple of weeks at Rice University.


As home to the world-renowned Texas Medical Center, Houston is at the forefront of state-of-the-art medical research and development. Yet the average Houstonian may know very little about the incredible advances being made in their own backyard. In this extraordinary opportunity, doctors and researchers representing two TMC institutions, Baylor College of Medicine and the Texas Heart Institute, will address a variety of cutting-edge developments, including molecular surgery, fetal surgery and new treatments for aging and addiction. Heart surgeon Denton Cooley will kick off the lecture series with a look at the past, present and future of the TMC and its dynamic institut...</description>
            <author>the story of healing</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=853138</comments>
            <pubDate>Sun, 09 Sep 2007 07:16:01 +0100</pubDate>
            <guid isPermaLink="false">853138</guid>        </item>
        <item>
            <title>Australia  Slows Brain Drain with Synchroton Investment</title>
            <link>http://www.medworm.com/index.php?rid=770827&amp;cid=t_163290_109_f&amp;fid=35677&amp;url=http%3A%2F%2Ffeeds.feedburner.com%2F%7Er%2FBrainBasedBusiness%2F%7E3%2F139225088%2Fsynchroton_slows_brain_brain_i.html</link>
            <description>What does your firm or area do to keep talented and creative people? US Census Bureau findings show brain drain as a problem in many states. And it&amp;rsquo;s happening in other once vibrant nations too. Check out how creative scientists in Australia are fighting back.&amp;nbsp; How so?The construction of Australia&amp;#39;s first synchrotron at Monash is considered to be the most significant scientific infrastructure investment made in Australia for decades.Australia found an innovative niche for synchrotron that will help reverse &amp;#39;brain drain&amp;#39; Recently,&amp;nbsp; scientists in Melbourne opened Australia&amp;#39;s first synchrotron, a move that is expected to keep the country on the cusp &amp;nbsp;of research for decades to come.Unveiled in Melbourne today, this $220 million machine spreads to football ...</description>
            <author>BrainBasedBusiness</author>
            <type>blogs</type>
        <comments>http://www.medworm.com/rss/comments.php?id=770827</comments>
            <pubDate>Tue, 31 Jul 2007 15:02:29 +0100</pubDate>
            <guid isPermaLink="false">770827</guid>        </item>
    </channel>
</rss>

